Lim Sujin’s book
POL-2022-115743
Hanbit Cancer Care Plus
Hong Taeyang · ₩149k/mo · Lapsed · applied Mar 15, 2022
Contract risksimulated
27.0Low
Engine verdict
simulatedNo conduct signal — metrics within cohort norms.
No findings — production, payment, and service signals on this contract are within cohort norms.
Contract facts
The ledger fields the verdict reads. Highlighted values are the ones that tripped a finding.
- Product
- Hanbit Cancer Care Plus · Cancer
- Policyholder
- Hong Taeyang
- Monthly premium
- ₩149k
- Status
- Lapsed
- Applied
- Mar 15, 2022
- Issued
- Mar 17, 2022
- Lapsed
- Jul 16, 2023
- Happycall
- Completed
- Replacement declared
- No
- Comparison notice
- —
- Payer relation
- Self
Agent rollup
Writing agentNo agent-level flag draws on this contract. It contributes its verdict to the writing agent’s book rollup.
Lim Sujin
AGT-1066 · Seoul Central Branch Office 2
Analysis record
- Engine
- signalgraph-contract-analyzer
- Version
- sim-0.4 · v1
- Analyzed
- Feb 9, 2026
- Trigger
- Initial Batch
- Status
- Complete
- Input fingerprint
- sha256:31db10c7…
Mirrors the sales.contract_analysis row the engine will write. Values are simulated preview.